Sub-Community 于重元 [19/19] 劉柯俊 [85/98] 劉滄梧 [119/125] 劉界元(2003-2010) [3/3] 夏和雄(1996-2012) [26/31] 夏興國 [51/54] 姜乃榕 [82/94] 常慧如 [39/44] 張俊彥 [234/254] 張光裕 [69/79] 張憶壽 [103/106] 張文祥 [52/53] 張書銘 [89/91] 彭汪嘉康(1996-2007) [120/126] 施能耀 [37/43] 李家惠 [29/29] 李岳倫 [48/49] 林素芳 [32/32] 楊奕馨 [41/42] 江士昇 [88/90] 沈哲宏 [14/16] 洪文俊 [88/88] 莊雙恩 [82/91] 蔡坤志 [32/34] 蔡慧珍 [66/71] 蘇勇曄 [40/40] 蘇振良 [24/25] 郭靜娟 [71/76] 陳尚鴻 [45/48] 陳振陽 [72/72] 陳立宗 [443/510] 陳美霞(2002-2009) [1/1] 陳詩政 [2/2] 陳雅雯 [38/39] 黃智興 [55/55] 黃道揚 [26/26] 丁兆治(2000-2004) [5/5] 其他 [464/471] 劉敏(1996-2007) [60/62] 劉玫英(2004-2006) [2/2] 吳成文(1996-2008) [53/55] 曾思文(1997-2007) [4/4] 李冠德(1997-2004) [4/6] 林景太(1999-2007) [5/5] 楊文光(1996-1999) [21/21] 王全正(1996-2003) [4/4] 莊聲宏(1997-2004) [11/11] 詹宗晃(2000-2008) [2/2] 賴基銘(2004-2008) [41/47] 阮麗蓉(2000-2006) [6/7] 陳俊叡(2003-2007) [6/6] 馬彥英(1997-1999) [1/1] 黃奇英(2005-2007) [9/10] Siblings 分子與基因醫學研究所 [921/964] 生技與藥物研究所 [830/1008] 生醫工程與奈米醫學研究所 [1214/1334] 免疫醫學研究中心 [224/236] 神經及精神醫學研究中心 [782/804] 細胞及系統醫學研究所 [755/815] 感染症與疫苗研究所 [1541/1618] 群體健康科學研究所 [2870/3000] 國家環境醫學研究所 [1560/1591] 國家蚊媒傳染病防治研究中心 [102/104] 高齡醫學暨健康福祉研究中心 [216/224] 論壇 [2/2] 生醫資源中心 [7/7] 研究生培育合作學程 [188/191] 核心儀器設施中心 [9/9] 病理核心實驗室 [14/14] 實驗動物中心 [8/8] 行政管理部門 [18/18] Community Statistics 近3年內發表的文件:335(13.91%) 含全文筆數:2250(93.40%) 文件下載次數統計 下載大於0次:2250(100.00%) 下載大於100次:2250(100.00%) 檔案下載總次數:1611277(30.06%) 最後更新時間: 2024-11-28 18:37 Top Upload Loading... Top Download Loading... Recent Submissions Pathological response following neo... Registry of genetic alterations of ... Activated single nucleotide mismatc... Taiwan nationwide study of first-li... The effectiveness of virtual passpo... Special Issue "Bioinformatics ... Evaluating a natural language proce... The clinicopathological significanc... Hypoxia in drug resistance and radi... DKK1 as a chemoresistant protein mo...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 201-225 of 2409. (97 Page(s) Totally) << < 4 5 6 7 8 9 10 11 12 13 > >> View [10|25|50] records per page

Date	Title	Relation
2022-12-23	The dietary flavonol kaempferol inhibits epstein-barr virus reactivation in nasopharyngeal carcinoma cells	Molecules. 2022 Dec 23;27(23):Article number 8158.
2022-12-22	Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-kappaB and TGF-Beta2 signaling	Journal of Biomedical Science. 2022 Dec 22;29:Article number 109.
2022-12-15	An integrated microfluidic system for cholangiocarcinoma diagnosis from bile by using specific affinity probes	Sensors and Actuators B-Chemical. 2022 Dec 15;373:Article number 132724.
2022-12-15	Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway	Life Sciences. 2022 Dec 15;311(Part A):Article number 121135.
2022-12-01	Dihydromyricetin inhibited migration and invasion by reducing S100A4 expression through ERK1/2/beta-catenin pathway in human cervical cancer cell lines	International Journal of Molecular Sciences. 2022 Dec 1;23(23):Article number 15106.
2022-12-01	Methylation of TET2 promoter is associated with global hypomethylation and hypohydroxymethylation in peripheral blood mononuclear cells of systemic lupus erythematosus patients	Diagnostics. 2022 Dec 1;12(12):Article number 3006.
2022-12	Recalibrating risk prediction models by synthesizing data sources: Adapting the lung cancer PLCO model for Taiwan	Cancer Epidemiology, Biomarkers and Prevention. 2022 Dec 5;31(12):2208-2218.
2022-12	Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer	Annals of Oncology. 2022 Dec;33(12):1250-1268.
2022-12	Mitochondrial AAA protease gene associated with immune infiltration is a prognostic biomarker in human ovarian cancer	Pathology Research and Practice. 2022 Dec;240:Article number 154215.
2022-12	Distinct immunogenetic profiles of chronic lymphocytic leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study	HemaSphere. 2022 Dec;6(12):Article number e803.
2022-12	PARP1 recruits DNA translocases to restrain DNA replication and facilitate DNA repair	PLoS Genetics. 2022 Dec;18(12):Article number e1010545.
2022-11-24	High vs. low radiotherapy dose in locally advanced esophageal squamous cell carcinoma patients treated with neoadjuvant concurrent chemoradiotherapy: An endemic area population-based study	Discover Oncology. 2022 Nov 24;13:Article number 130.
2022-11-15	The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma	American Journal of Cancer Research. 2022 Nov 15;12(11):5062-5073.
2022-11-14	Optimizing margin status for improving prognosis in patients with oral cavity squamous cell carcinoma: A retrospective study from the two highest-volume Taiwanese hospitals	Frontiers in Oncology. 2022 Nov 14;12:Article number 1019555.
2022-11-06	PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation	Journal of Biomedical Science. 2022 Nov 06;29:Article number 92.
2022-11-01	Revisiting the cerebral hemodynamics of awake, freely moving rats with repeated ketamine self-administration using a miniature photoacoustic imaging system	Neurophotonics. 2022 Nov 01;9(4):Article number 045003.
2022-11	CHK2 activation contributes to the development of oxaliplatin resistance in colorectal cancer	British Journal of Cancer. 2022 Nov;127(9):1615-1628.
2022-11	High SLC28A2 expression endows an inferior survival for rectal cancer patients managed by neoadjuvant CCRT	Pathology, Research and Practice. 2022 Nov;239:Article number 154158.
2022-11	Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in patients (pts) with advanced biliary tract cancer (BTC)	Annals of Oncology. 2022 Nov;33(Suppl. 9):S1462-S1463.
2022-11	BEAR study: A single-arm, phase II trial of BI-754091 and afatinib for refractory esophageal squamous cell carcinoma	Annals of Oncology. 2022 Nov;33(Suppl. 9):S1472-S1473.
2022-11	PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan	Journal of the American Society of Nephrology. 2022 Nov;33(11S):150.
2022-11	Comparison of single-cell transcriptomic profiles of early and late peritoneal dialysis	Journal of the American Society of Nephrology. 2022 Nov;33(11S):449.
2022-10-31	PD-L1 expression in high-risk early-stage colorectal cancer-its clinical and biological significance in immune microenvironment	International Journal of Molecular Sciences. 2022 Oct 31;23(21):Article number 13277.
2022-10-30	Multi-omics analysis reveals clinical value and possible mechanisms of ATAD1 down-regulation in human prostate adenocarcinoma	Life. 2022 Oct 30;12(11):Article number 1742.
2022-10-27	A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies	Nature Methods. 2022 Oct 27;19:1599-1611.

Showing items 201-225 of 2409. (97 Page(s) Totally) << < 4 5 6 7 8 9 10 11 12 13 > >> View [10|25|50] records per page